SKU: SURV 10

Survodutide 10mg – Research-Grade Peptide

Product Overview Survodutide (BI 456906, CAS 2805997-46-8) is a potent, investigational dual agonist targeting both the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R). Designed for advanced preclinical and in vitro research applications, this synthetic peptide compound facilitates studies into metabolic pathways, including energy expenditure, appetite regulation, and lipid metabolism. Each vial contains 10mg of high-purity (≥99%) lyophilized powder, suitable for reconstitution in sterile aqueous solutions.

Key Research Attributes

• Mechanism of Action: Activates dual receptor pathways to modulate glucose homeostasis, hepatic fat reduction, and body weight dynamics in experimental models. Ideal for exploring glucagon-mediated effects beyond traditional GLP-1 agonists.
• Dose-Response Profile: Supports dose-ranging experiments, with literature indicating up to 18.7% body weight modulation in phase 2 models at comparable doses (e.g., 4.8mg equivalents).
• Stability and Handling: Lyophilized form ensures long-term stability at -20°C; reconstitute with bacteriostatic water for immediate use in cell culture or animal studies.
• Purity and Quality: Sourced from certified suppliers; high-purity (≥99%); see our COA page